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ABSTRACT Interferon-regulated immune defenses protect mammals from patho-
genically diverse obligate intracellular bacterial pathogens of the genus Chla-
mydia. Interferon gamma (IFN-) is especially important in controlling the viru-
lence of Chlamydia species and thus impacts the modeling of human chlamydial
infection and disease in mice. How IFN- contributes to cell-autonomous defenses
against Chlamydia species and how these pathogens evade IFN--mediated immunity in
their natural hosts are not well understood. We conducted a genetic screen which
identified 31 IFN--sensitive (Igs) mutants of the mouse model pathogen Chla-
mydia muridarum. Genetic suppressor analysis and lateral gene transfer were
used to map the phenotype of one of these mutants, Igs4, to a missense muta-
tion in a putative chlamydial inclusion membrane protein, TC0574. We observed
the lytic destruction of Igs4-occupied inclusions and accompanying host cell
death in response to IFN- priming or various proapoptotic stimuli. However,
Igs4 was insensitive to IFN--regulated cell-autonomous defenses previously im-
plicated in anti-Chlamydia trachomatis host defense in mice. Igs4 inclusion integ-
rity was restored by caspase inhibitors, indicating that the IFN--mediated de-
struction of Igs4 inclusions is dependent upon the function of caspases or
related prodeath cysteine proteases. We further demonstrated that the Igs4 mu-
tant is immune restricted in an IFN--dependent manner in a mouse infection
model, thereby implicating IFN--mediated inclusion destruction and host cell
death as potent in vivo host defense mechanisms to which wild-type C. muri-
darum is resistant. Overall, our results suggest that C. muridarum evolved resis-
tance mechanisms to counter IFN--elicited programmed cell death and the as-
sociated destruction of intravacuolar pathogens.
IMPORTANCE Multiple obligatory intracellular bacteria in the genus Chlamydia are
important pathogens. In humans, strains of C. trachomatis cause trachoma, chla-
mydia, and lymphogranuloma venereum. These diseases are all associated with ex-
tended courses of infection and reinfection that likely reflect the ability of chlamyd-
iae to evade various aspects of host immune responses. Interferon-stimulated genes,
driven in part by the cytokine interferon gamma, restrict the host range of various
Chlamydia species, but how these pathogens evade interferon-stimulated genes in
their definitive host is poorly understood. Various Chlamydia species can inhibit
death of their host cells and may have evolved this strategy to evade prodeath sig-
nals elicited by host immune responses. We present evidence that chlamydia-
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induced programmed cell death resistance evolved to counter interferon- and
immune-mediated killing of Chlamydia-infected cells.
KEYWORDS Chlamydia, host-pathogen interactions, interferon-stimulated genes,
intracellular pathogens, molecular genetics
Obligate intracellular bacteria in the genus Chlamydia, including the human patho-gen Chlamydia trachomatis, undergo a developmental cycle in which they transi-
tion between infectious elementary body (EB) and noninfectious replicative reticulate
body (RB) forms. Immune-mediated changes in host cell metabolism, including the
degradation of intracellular tryptophan by the interferon gamma (IFN-)-inducible
enzyme indole-2,3-dioxygenase, prompt physiological changes in C. trachomatis. For
example, tryptophan starvation causes RBs to transition into nonreplicative aberrant
forms, which persist without dividing or transitioning into EBs (1, 2). Under tryptophan
starvation conditions, C. trachomatis genital strains express a partial tryptophan operon
enabling the synthesis of tryptophan from indole, which may be derived from the
genital microbiome, and are thereby able to survive in a tryptophan-depleted intra-
cellular environment (3–6). C. trachomatis and Chlamydia muridarum can also block cell
death in epithelial cells exposed to prodeath signals (7, 8). These observations suggest
that Chlamydia spp. counter intracellular immune defenses while maintaining the
viability of their host cell to complete a productive developmental cycle. However, the
pertinent host defenses, including the trigger of prodeath pathways and the corre-
sponding immune evasion mechanisms employed by different Chlamydia spp. remain
largely unexplored.
The Th1 cytokine interferon gamma (IFN-) plays a central role in the immune
protection of mice and humans against Chlamydia spp. (9). IFN- induces the expres-
sion of interferon-stimulated genes (ISGs), which mediate cell-autonomous defenses
that clear intracellular pathogens (9–11). Multiple ISG-mediated cell-autonomous host
defenses protect mice against experimental C. trachomatis infection (3, 9, 12–18). In
contrast to C. trachomatis, mice are significantly more susceptible to infection and
disease mediated by the rodent-adapted pathogen C. muridarum, presumably because
C. muridarum encodes host-tailored virulence factors that help it counter the relevant
IFN--regulated cell-autonomous defenses of its definitive murine host (5, 16). Identi-
fication of the virulence factors that C. muridarum and C. trachomatis use to circumvent
conserved and host-specific IFN--regulated cell-autonomous host defense mecha-
nisms could provide insight into mechanisms of chlamydial pathogenesis and guide
the development of improved mouse models of C. trachomatis infection and disease
(5, 19).
Increasing evidence suggests that programmed cell death resistance (PCDR) elicited
by Chlamydia spp. is an ancient virulence strategy that contributes to chlamydial
pathogenesis. Chlamydia-infected cells resist killing by a various synthetic and immune
stimuli that elicit apoptosis of uninfected cells in vitro (7, 8, 20, 21), and PCDR may
protect Chlamydia-infected cells from immune-mediated death signals (22, 23). The
microbe’s ability to maintain integrity of its inclusion membrane is critical for the
survival of C. trachomatis-infected host cells. Loss-of-function mutations in several
inclusion membrane proteins (Incs; e.g., CpoS) prompt inclusion lysis and trigger cell
death emanating from the destabilized inclusion (24, 25). Infection with Inc mutants
deficient for inclusion maintenance triggers host cell death dependent on the au-
tophagy protein Beclin1 and the cytosolic immune sensor stimulator of interferon
genes (STING) but independent of the STING-mediated type I IFN response (24). Thus,
the loss of inclusion integrity induces death pathways that override chlamydial PCDR.
While Inc deficiencies can destabilize inclusions, host cell priming with IFN- can induce
the disruption of inclusions formed by wild-type C. trachomatis inside mouse fibroblasts
(26). Thus, an IFN--mediated host response can override chlamydial PCDR, albeit only
in mouse cells infected with C. trachomatis. However, neither the IFN--activated host
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response leading to inclusion disruption nor the chlamydial factors counteracting this
membranolytic host defense program have been identified.
The goal of this study was to identify C. muridarum genes that counter IFN--
regulated cell-autonomous defenses in mice. We identified interferon gamma-sensitive
(Igs) C. muridarum mutants using a genetic screen. IFN--mediated killing of one of
these mutants, Igs4, was linked to an amino acid substitution in a putative chlamydial
Inc protein. Interferon priming and proapoptotic stimuli compromised Igs4 inclusions
and killed Igs4-infected mouse cells. Caspase inhibitors blocked both host cell death
and lysis of Igs4 inclusions in IFN--primed cells, suggesting that prodeath cysteine
proteases operate upstream of inclusion lysis. Importantly, attenuation of Igs4 in
wild-type mice was reversed in IFN- knockout (IFN- /) mice, demonstrating the
relevance of our in vitro observations in a model that mimics human genital chlamydia.
Overall, our results show that chlamydial PCDR and interferon resistance are linked and
suggest that C. muridarum has evolved mechanisms to protect inclusions against an
IFN--triggered membranolytic pathway executed by prodeath cysteine proteases.
RESULTS
Isolation of IFN--sensitive Chlamydia muridarummutants. C. trachomatis and C.
muridarum infect a variety of mouse epithelial and fibroblastic cell lines, including
McCoy fibroblasts (McCoy cells) (3, 16). However, low doses of IFN- block C. tracho-
matis but not C. muridarum proliferation in McCoy cells, indicating that C. muridarum is
equipped with virulence factors that counteract host defenses active in IFN--primed
mouse cells. To identify these factors, we designed a genetic screen comparing the
inclusion formation of wild-type C. muridarum and 2,976 ethyl methanesulfonate
(EMS)-mutagenized C. muridarum isolates in IFN--primed and unprimed McCoy cells.
IFN- reduced C. muridarum inclusion formation, a measure of infectivity, in McCoy
cells by approximately 20% (Fig. 1A). We identified 31 IFN--sensitive (Igs) C. muridarum
mutants that were more sensitive to IFN- than wild-type C. muridarum. Temporal
inclusion and progeny assays were used to characterize four mutants, Igs1 to Igs4
(Fig. 1). IFN- strongly inhibited progeny production of these Igs mutants at 18, 24, and
30 h postinfection (hpi) (P  0.001) (Fig. 1C to J). IFN- almost completely abrogated
progeny production of Igs4 (Fig. 1J), and the number of Igs4 genomes began to decline
between 18 and 24 hpi (see Fig. S1 in the supplemental material), suggesting that IFN-
induced killing of this mutant in McCoy cells.
An amino acid substitution in an inclusion membrane protein confers Igs4
IFN- sensitivity. We compared the genomes of several Igs mutants, but the relatively
high mutation loads in the mutants and the various strengths of their IFN--sensitivity
phenotypes confounded attempts to identify the relevant mutations (Table S1). As an
alternative strategy to identify causative mutations, we serially passaged Igs4 in IFN-
-primed McCoy cells to isolate revertants whose resistance to IFN--induced cell-
intrinsic immunity was restored in mouse cells. Genome resequencing of select rever-
tants revealed that most of them were isogenic to Igs4, except for new mutations in
tc0574 (Table S1). Since Igs4 carries a mutant tc0574 allele (tc0574G242A) that introduces
a nonsynonymous amino acid change in TC0574 (TC0574G81E), this indicated that the
new mutations in tc0574 of the revertants suppressed the effects of the mutant tc0574
allele in Igs4 (Fig. 2). Targeted sequencing of the tc0574 locus identified new mutations
in tc0574 in 22 of the isolates (8 unique genotypes, S1 to S8) and a point mutation that
destroyed the predicted start codon of the upstream gene tc0573 in one isolate (S9)
(Fig. 2A). None of these mutations were silent, and 2 of the 9 mutations introduced stop
codons in tc0574, showing that destroying TC0574G81E mutant protein or preventing its
expression suppressed the IFN- sensitivity conferred by the original mutation. Since
inclusion and progeny production of the Igs4 suppressor mutants were similar to C.
muridarum in IFN--primed cells, this also showed that wild-type TC0574 is normally
dispensable for C. muridarum IFN- resistance (Fig. 2B and C). We confirmed that
tc0574G242A caused Igs4 IFN--sensitivity using counterselection lateral gene transfer
(27, 28). IFN--resistant recombinants from a cross of Igs4 with a temperature-sensitive
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C. muridarum mutant retained wild-type tc0574, and one recombinant, R5, retained all
the nonsynonymous alleles in Igs4 except for tc0574G242A (Fig. S2). We concluded that
a detrimental missense mutation in a putative inclusion membrane protein (Inc) gene
tc0574, which is normally dispensable for C. muridarum IFN- resistance, sensitizes Igs4
to IFN-.
Mechanisms of Igs4 and C. trachomatis IFN- sensitivity differ. In IFN--primed
mouse fibroblasts, C. trachomatis inclusions are targeted by GKS class immunity-related
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FIG 1 Development of Igs mutants is inhibited by IFN-. McCoy cells were infected at an MOI of 1 with
C. muridarum (CM) or Igs mutants (indicated in graphs)  IFN-. Inclusion-forming units (A, C, E, G, and
I) and progeny (B, D, F, H, and J) were counted at different intervals postinfection. The y axis in the
progeny experiments indicates burst size (number of inclusions counted in the progeny relative to the
input inclusion-forming units in the original infection). Graphs show results of three experiments
performed in triplicate, and error bars show standard deviation. IFN-, closed circles; IFN-, open
circles. Corresponding infections  IFN- were compared by two-way ANOVA with Bonferroni posttest.
*, P 0.05; ***, P 0.001.
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guanosine phosphatases (IRGs) that promote inclusion disruption and elimination of
the bacteria, likely via autolysosomes (12, 15, 29). To test whether Igs4 is sensitive to
IFN--mediated cell-autonomous defenses that restrict C. trachomatis in mouse cells,
we compared the subcellular localization of two GSK IRGs, Irgb10 and Irgb6, in cells
infected with C. trachomatis, C. muridarum, or Igs4. Irgb6 and Irgb10 localized to a
subpopulation of C. trachomatis, but not C. muridarum or Igs4, inclusions, suggesting
that Igs4 is not susceptible to an IRG-dependent host defense pathway (Fig. 3A). We
also tested if Igs4 progeny production was restored in cells that lack Irgm1 and Irgm3,
two regulatory proteins that mediate Irgb6 and Irgb10 delivery to inclusions (30).
Progeny production of C. trachomatis, but not of Igs4, increased in IFN--treated
irgm1/ or irgm3/ murine embryonic fibroblasts (MEFs), confirming that IFN--
mediated inhibition of Igs4 is independent of IRGs (Fig. 3B). The autophagy protein
Atg5 is essential for the delivery of IRGs and related interferon-inducible guanylate
binding proteins (GBPs) to C. trachomatis inclusions and the execution of antimicrobial
xenophagy (26, 30–32). Igs4 formed similar numbers of inclusions in IFN--primed
atg5/ and in wild-type MEFs, excluding the involvement of autophagy or autophagy-
related processes in the defense pathway that is effective against Igs4 (Fig. 3C). Finally,
C. muridarum EBs can rescue C. trachomatis progeny production and block the recruit-
ment of IRGs to C. trachomatis inclusions in IFN--primed mouse cells (15, 33). Igs4 and
C. muridarum similarly rescued C. trachomatis in coinfection rescue experiments in
IFN--primed McCoy cells (Fig. 3D). These data demonstrated that Igs4 is sensitive to an
IRG- and Atg5-independent IFN--inducible defense program and that Igs4 differs in
this regard from IRG-sensitive C. trachomatis.
FIG 2 Igs4 IFN- sensitivity is linked to a G81E substitution in TC0574. (A) Schematic of Igs4 TC0574G81E
and predicted amino acid changes in TC0573 and TC0574 in suppressor mutants S1 to S9. S9 is scaled
differently to include TC0573. All of the suppressor mutants retained TC0574G81E (black circle) from Igs4.
Hatched areas indicate untranslated regions of TC0574 caused by nonsense mutations (*), out-of-frame
insertions (ins), or frameshifts (Δ). Ratio of inclusion (B) and progeny production (C) of C. muridarum (CM),
Igs4, and S1 to S9 IFN-. Graphs show results from three experiments performed in triplicate, and error
bars show standard deviation. The ratios of Igs4 to S1 to S9 inclusion and progeny production  IFN-
were compared to C. muridarum by two-way ANOVA with Bonferroni posttest. ***, P 0.001.
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We tested if Igs4 was sensitive to other non-IRG IFN--mediated defenses that can
contribute to chlamydia clearance. For example, macrophage-expressed protein 1
(Mpeg1) contributes to killing of various Chlamydia spp. in fibroblasts (34). However, we
observed that C. trachomatis and Igs4 produced similar numbers of progeny in IFN--
primed wild-type MEFs and in MEFs in which Mpeg1 was knocked down using short
hairpin RNAs (shRNAs) (Fig. 4A). IFN- also induces the production of nitric oxide and
reactive oxygen species that can kill C. trachomatis (17, 18, 35, 36). C. trachomatis
elicited higher levels of inducible nitric oxide synthase (iNOS) expression and nitrite
production than did C. muridarum or Igs4 in McCoy cells (Fig. 4B and C). However, Igs4
progeny production was not rescued by the iNOS inhibitor N(G)-nitro-L-arginine methyl
ester (L-NAME) or the oxygen scavenger dimethylthiourea (DMTU) in IFN--treated
McCoy cells (Fig. 4D). These results showed that different IFN--mediated defenses
contribute to the inhibition of C. trachomatis and Igs4 in mouse cells.
Type I and type II interferons elicit lysis of Igs4 inclusions in mouse cells.
Lipopolysaccharide (LPS) staining revealed lysed Igs4 inclusions in untreated McCoy
cells and that the number of these lysed inclusions dramatically increased by 16 hpi in
IFN--primed cells. In contrast, lysed inclusions were rare in McCoy cells infected with
C. muridarum, C. trachomatis, other Igs mutants, or isogenic Igs4 suppressor mutants
(Fig. 5A and B). Igs4 displayed similar inclusion lysis phenotypes in OE129 and C57epi
mouse oviduct epithelial cells, suggesting that the host defense program restricting
Igs4 is also active in the cell type predominantly infected during genital C. muridarum
infections (Fig. S3A and B) (37, 38).
We asked whether restriction of Igs4 required the induction of de novo host protein
expression. Consistent with the involvement of host proteins in Igs4 inclusion lysis, the
eukaryotic translation inhibitor cycloheximide (CHX) blocked inclusion lysis in untreated
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FIG 3 Igs4 resists IRGs that inhibit C. trachomatis in mouse cells. (A) Irgb6 and Irgb10 targeting events
per 100 inclusions in C. muridarum (CM), C. trachomatis (CT), and Igs4-infected McCoy cells plus IFN-;
****, P 0.0001. (B and C) irgm1/ or irgm3/ (B) or atg5/ (C) MEFs were infected with C. muridarum,
C. trachomatis, or Igs4  IFN-, and the ratios of progeny the strains that produced  IFN- were
compared. **, P 0.01; ***, P 0.001; ns, not significant. (D) McCoy cells were infected with C. tracho-
matis rifr at an MOI of 1 or coinfected with C. trachomatis rifr at an MO1 and Igs4 or C. muridarum at MOIs
of 2 or 4  IFN- (indicated below bars). Rifampin was added in all experiments to inhibit C. muridarum
and Igs4. C. trachomatis rifr progeny were harvested at 24 hpi and counted in McCoy cells. Graph shows
the results from three experiments performed in triplicate, and error bars indicate standard deviation.
Progeny under various conditions were compared to C. trachomatis rifr plus IFN- by one-way ANOVA
with Bonferroni posttest. ****, P 0.001.
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McCoy cells (Fig. 5C). We then tested if Igs4 was sensitive to interferon beta (IFN-),
because Chlamydia spp. are potent inducers of this cytokine, and some ISGs are
cross-regulated by IFN- and IFN- (39, 40). Exogenous IFN- elicited excess Igs4 lysis
that was blocked by an antibody that blocks IFN- signaling through the type I
interferon receptor (IFNAR) but not by an isotype control antibody (Fig. 5C). However,
anti-IFNAR did not block Igs4 lysis in untreated McCoy cells, suggesting that Igs4
inclusion lysis in unprimed cells was IFNAR independent.
IFN- kills Igs4-infected McCoy cells. Chlamydia-infected cells resist various in-
ducers of programmed cell death (7), but transmission electron microscopy of Igs4-
infected IFN--primed McCoy cells revealed no intact inclusions and host cells that
exhibited signs of cell death, including nuclear degradation, membrane blebbing, and
increased intracellular vesicles (Fig. 6A). We tested if the McCoy cells were being killed
using acridine orange/ethidium bromide costaining (41). More dead McCoy cells were
detected in cultures infected with Igs4 than in cultures infected with C. muridarum, C.
trachomatis, or the isogenic Igs4 suppressor mutant S5 (Fig. 6B). Priming with IFN-
increased cell death in Igs4-infected McCoy cells at 16 hpi, corresponding with in-
creased inclusion lysis, suggesting that inclusion lysis and host cell death occur in close
succession (Fig. 6B and C).
IFN--mediated lysis of Igs4-infected cells is blocked by caspase inhibitors.
Necrostatin-1, an receptor interacting protein 1 (RIP-1) kinase inhibitor, blocked ne-
crotic killing of McCoy cells induced by a combination of tumor necrosis factor-alpha
(TNF-) and the pancaspase inhibitor Z-VAD(OMe)-fmk (ZVAD) (Fig. S4A) (42, 43).
However, necrostatin-1 failed to block lysis of Igs4 inclusions in IFN--treated cells
(Fig. S4B). In contrast, Z-VAD inhibited Igs4 lysis in IFN--treated cells in a dose-
dependent manner, and Igs4 lysis was completely blocked by 200 M ZVAD (Fig. 7).
These results suggested that Igs4 inclusion lysis was mediated by caspases (44).
Because Z-VAD can have off-target effects, we tested if caspase-specific inhibitors
rescued Igs4 lysis (44). Caspase-3 (Z-DEVD-FMK), caspase-8 (Z-IETD-FMK), and caspase-9
(Z-LEHD-FMK) inhibitors partially blocked IFN--mediated Igs4 lysis (Fig. S5), suggesting
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FIG 4 Igs4 resists non-IRG IFN- defenses that inhibit other Chlamydia spp. (A) Mpeg1 transcript was knocked
down 70% in MEFs utilizing shRNA MPEG#1 or MPEG #2. The ratios of the progeny C. muridarum (CM), C.
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C. trachomatis, Igs4, S1, or S5  IFN- and L-NAME at 24 hpi; **, P 0.01; ***, P 0.001; ****, P 0.0001. (D)
Progeny production of C. muridarum, C. trachomatis, Igs4, S1, or S5 in untreated McCoy cells (control) compared
to McCoy cells treated with IFN-, IFN- plus L-NAME, IFN- plus dimethyl thioureau (DMTU), or IFN- plus L-NAME
plus DMTU at 24 hpi. Error bars indicate standard deviations, and data were analyzed by two-way ANOVA with
Bonferroni posttest. None of the differences were significant.
Chlamydia Interferon and Cell Death Evasion Are Linked ®
March/April 2019 Volume 10 Issue 2 e00385-19 mbio.asm.org 7
that several caspases contribute to, but are not sufficient to elicit, Igs4 lysis (45–47).
Unexpectedly, the levels of processed caspases-3, -8, and -9 were low in C. muridarum-
and Igs4-infected cells in the presence and absence of IFN- (Fig. S6). These results
suggested that Igs4 inclusion integrity is sensitive to small amounts of active caspases
or that atypical caspases or other cysteine proteases mediate Igs4 lysis (48, 49).
Apoptosis inducers elicit Igs4 lysis in the absence of IFN-. Our results suggested
that IFN--mediated lysis of Igs4 was mediated by capsases and or other cysteine
proteases but not how these were activated. We hypothesized that caspase activation
could result from the release of chlamydial antigens following inclusion lysis, or
activation might precede and drive Igs4 lysis (Fig. 8). To determine whether caspase
activation is sufficient to drive Igs4 inclusion lysis, we tested if apoptosis inducers lysed
Igs4 inclusions in the absence of IFN-. Both staurosporine, an intrinsic apoptosis
inducer, alone and TNF- plus CHX, an extrinsic apoptosis inducer, lysed Igs4 in the
absence of IFN- (Fig. 9A and B). Neither treatment lysed C. muridarum, C. trachomatis,
or S5 inclusions. In contrast, a necrosis inducer, TNF- plus Z-VAD, did not lyse Igs4
inclusions (Fig. 9C). These results suggested that Igs4 inclusions are sensitive to
caspase-mediated rupture (Fig. 8).
Igs4 attenuation in the murine genital tract is IFN- dependent. To determine
the physiological impact of this novel IFN--inducible membranolytic host defense
pathway, we evaluated Igs4 virulence in a murine genital tract model. Infection
duration and EB shedding were similar in C57BL/B6 mice infected with C. muridarum or
with two different suppressor mutants isogenic to Igs4 (S1 and S5), confirming that
background mutations in Igs4 do not impact its virulence (Fig. 10A). In contrast,
wild-type mice cleared Igs4 earlier and shed fewer infectious EBs (Fig. 10B). Igs4 EB
shedding decreased sharply 7 to 10 days postinfection (dpi), which is when CD4 T cells
begin to emigrate to the genital tract and shortly after IFN- levels peak in this model
(50–52) (Fig. 10B). Igs4-infected mice also did not develop hydrosalpinx (0/10), whereas
A.
B. C.
IFNγ
IFNγ
FIG 5 Type I and II interferons elicit lysis of Igs4 inclusions. (A) McCoy cell monolayers were infected with
C. muridarum (CM), C. trachomatis (CT), or Igs4 at an MOI of 0.1  IFN-. The infected cells were fixed at
24 hpi and labeled with anti-LPS (green), DAPI (blue), and Evans blue (red). (B) Representative Igs4
inclusions labeled as described in panel A. (C) Mean percent intact inclusions in IFN--, IFN--, -IFNAR-,
-IFNAR plus IFN--, or CHX-treated McCoy cells at 24 hpi from two experiments performed in triplicate.
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most mice infected with C. muridarum or the suppressor mutants did (C. muridarum, 9/9
mice; S1, 10/10 mice; S5, 7/9 mice). Attenuation of Igs4 was IFN- dependent. The
duration and magnitude of Igs4 shedding in IFN- / mice did not significantly differ
from C. muridarum from mid-late infection onwards (Fig. 10C). Notably, Igs4-infected
IFN- / mice shed fewer EBs than did C. muridarum-infected IFN- / mice at 3 dpi,
FIG 6 Igs4-infected IFN--treated McCoy cells undergo increased cell death. (A) Representative TEM images of McCoy cells infected
with C. muridarum (CM), Igs4, or S5  IFN-. (B) McCoy cells were infected with C. muridarum, Igs4, S5, or C. trachomatis (CT) at an
MOI of 1  IFN-, and the percent dead McCoy cells was determined using acridine orange and ethidium bromide costaining at
various intervals postinfection. (C) Same as in panel B, except the infections were performed at an MOI of 0.1, and lysed inclusions were
identified by staining chlamydial LPS. Graphs in panels B and C show results from three experiments performed in triplicate, and error
bars show standard deviation. Results with Igs4 and C. muridarum were compared to other conditions by two-way ANOVA with
Bonferroni posttest. ns, not significant; ****, P 0.0001.
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when type I interferon levels are high in this model (53, 54). Igs4 EB shedding also
trended lower until 10 dpi, possibly reflecting the switch from a type I to a type II
interferon-dominated environment. Collectively, these data indicate that an IFN--
driven and cysteine protease-dependent host defense program, resulting in inclusion
lysis, potently sterilizes genital Chlamydia infections in vivo.
DISCUSSION
Chlamydial interferon evasion is key to the virulence of multiple Chlamydia spp. in
mammals (51, 53, 55, 56), but few genes that contribute to chlamydial interferon
resistance have been characterized (28, 57, 58). We identified 31 Igs C. muridarum
mutants using a genetic screen. The Igs mutants exhibited an array of phenotypes and
contained few mutations in the same genes, indicating that C. muridarum IFN-
resistance is a complex phenotype (Fig. 1 and Table S1). This result may reflect inability
of a single chlamydial effector to counteract mechanistically distinct IFN--mediated
cell-autonomous defenses and the importance of IFN- resistance in C. muridarum
virulence.
We focused our follow-up studies on Igs4, which showed a reproducible phenotype
with a substantial effect size. To identify the causative mutation in Igs4, we conducted
a suppressor screen and found that several Igs4 suppressor mutants had mutations that
inactivate TC0574, indicating that tc0574 is dispensable for chlamydial IFN- and
FIG 7 Lysis of Igs4 inclusions can be blocked by caspase inhibitors. McCoy cells plus IFN- were treated with various
concentrations of Z-VAD (OMe)-fmk in DMSO or DMSO vehicle alone for 2 h and then infected with C. muridarum (CM), Igs4,
or C. trachomatis (CT) at an MOI of 0.1. The infected cells were incubated with the same inhibitors (indicated below graphs)
and IFN- until intact inclusions were counted at 24 hpi. Results from three experiments performed in triplicate are shown,
error bars indicate standard deviation, and the results were analyzed by two-way ANOVA with Šidák’s multiple comparison.
*, P 0.05; ****, P 0.0001. WT, wild type.
FIG 8 Two potential routes of Igs4 inclusion lysis and host cell death. In model 1, IFN- activates
unknown membranolytic factors that disrupt Igs4 inclusions. Introduction of the inclusion contents into
the cytoplasm then elicits activation of caspases that elicit host cell killing. In model 2, infection and IFN-
are sufficient to elicit activation of caspases or other cysteine proteases that lyse Igs4 inclusions.
Introduction of the inclusion contents into the cytoplasm elicits host cell death.
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apoptosis resistance and that the specific tc0574 mutation found in Igs4 (TC0574G81E)
rendered the mutant highly sensitive to an IFN--inducible cell-intrinsic immune pro-
gram. How this single amino acid change in TC0574 confers IFN- sensitivity remains
unclear.
TC0574 is predicted to be an Inc based upon the presence of a hydrophobic
bilobed domain (59, 60). Similar to a prior study that attempted to localize the C.
trachomatis TC0574 ortholog (CT0300) (61), we were unable to confirm inclusion
membrane localization of TC0574. A Phyre2 model predicts that TC0574 contains
two tightly packed -helices (amino acids [aa] 41 to 63 and aa 76 to 98) and that
G81 locates to the interface of these helices (Fig. S7) (62). The core region between
two similar -helices in IncA regulates homodimer formation and can block soluble
N-ethylmaleimide-sensitive factor attachment receptor (SNARE)-mediated and ho-
motypic inclusion fusion (63). We speculate that disruption of TC0574 folding alters
interactions with other proteins that mediate resistance of C. muridarum inclusions
to cysteine proteases.
Chlamydia-infected cells resist apoptosis inducers, including staurosporine (kinase
inhibitor), etoposide (DNA-damaging agent), TNF-, Fas antibody, granzyme, and
perforin (7). Chlamydia PCDR has been associated with inhibition of the proapoptotic
proteins Bax and Bak, upregulation and stabilization of the antiapoptotic protein Mcl1,
upregulation and translocalization of hexokinase II to the mitochondrion, and blocking
internalization of TNF--TNFR1 complexes (7, 8, 64–69). Broadly, chlamydial apoptosis
resistance appears to occur upstream of mitochondrial membrane destabilization and
the release of inner membrane components. Sensitivity of Igs4-infected cells to stau-
rosporine, and to TNF- plus CHX, which activate caspase-3 and -8, respectively, implies
that Igs4 cannot inhibit upstream or downstream steps in the caspase cascade. Type I
FIG 9 Inducers of apoptosis, but not necrosis, can elicit lysis of Igs4 inclusions. McCoy cells were infected at an MOI of 0.1 with C. muridarum (CM), Igs4, S5,
or C. trachomatis (CT). At 20 hpi, 1 M staurosporine (A), 5 ng/ml TNF- plus 10 g/ml CHX (B), 5 ng/ml TNF- plus 10 M Z-VAD (OMe)-fmk (C), or vehicle was
added, or the cells were left untreated. The cells were fixed 4 h later, and the percent lysed inclusions was determined. Graphs in panels A to C show the results
fom three experiments performed in triplicate, error bars indicate standard deviation, and the results were analyzed by two-way ANOVA with Šidák’s multiple
comparison. *, P 0.05; **, P 0.005.
FIG 10 Igs4 attenuation in C57BL/6 is reversed in IFN- / mice. (A) Vaginal EB shedding from C57/B6 mice infected with C. muridarum (wt), S1, or S5. (B)
Vaginal EB shedding from C57/B6 mice infected with C. muridarum or Igs4. (C) Vaginal EB shedding from IFN- / mice infected with Igs4 or C. muridarum.
EB data are presented for individual mice and as mean (log10) inclusion-forming unit shedding  the standard deviation. The data presented in panels A and
B were collected from concurrently infected mice, and the C. muridarum infection data are presented in both panels for clarity. *, P 0.05; **, P 0.01; ***,
P 0.001; ****, P 0.0001.
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and II interferons increase procaspase-8 expression and synergize with TNF- to trigger
FADD-mediated procaspase-8 processing (70), so TNF- plus CHX and interferon may
elicit lysis of Igs4 inclusions by this pathway. Blockage of IFN--mediated Igs4 inclusion
lysis by ZVAD and its partial inhibition by individual caspase inhibitors suggest the
contribution of multiple caspases but do not clarify which caspases drive inclusion lysis
or exclude the involvement of other cysteine proteases, such as calpains, which
promote lysis of C. trachomatis inclusions triggered by laser ablation (71). Our failure to
detect increased levels of caspases in the absence of staurosporine could indicate that
classical initiator and executioner caspases are not major mediators of Igs4 lysis or
could reflect exquisite sensitivity of the Igs4 inclusion to low levels of active caspases
(Fig. S6).
Inactivation of some Incs elicits inclusion instability in diverse cell lines and in the
absence of specific stimuli. It was proposed that the inclusion lysis phenotype of a
chlamydial promoter of survival (CpoS) mutant indicated a specific role for CpoS in
shielding host cells from prodeath signals and STING-mediated induction of type I
interferons (24). Another study showed that inactivation of other Incs (CT0229, IncC,
and CT0383) destabilizes the inclusion and suggested that STING activation is a
common endpoint of release of inclusion contents into the cytosol (25). Lysis of CpoSs,
IncC, CT0229, and CT0383 mutant inclusions is insensitive to caspase inhibitors, arguing
that caspase activation in cells infected with these mutants is a consequence, and not
a cause, of inclusion lysis (24, 25). When C. trachomatis inclusions were lysed using laser
ablation, their host cells were rapidly killed via an undefined necrotic pathway that does
not require BAX, BAK, RIP-1, or caspases (71). High doses of TNF- plus CHX can also
elicit necrotic killing of C. trachomatis-infected cells via a noncanonical pathway that is
caspase-8 dependent (72). Interpreting these observations in the context of our results,
we hypothesize that Chlamydia spp. employ effectors that counter cytokine-mediated
activation of caspases, but that release of chlamydial antigens following loss of inclu-
sion integrity invariably leads to initiation of a poorly defined pathway of programmed
cell death (Fig. 8).
In conclusion, Chlamydia-infected cells exhibit profound PCDR. Based upon our
observations that Igs4 responds similarly to interferon and nonimmune apoptotic
stimuli in mouse cells, that Igs4 inclusion rupture is blocked by cysteine protease
inhibitors, and that Igs4 virulence is rescued in IFN-/ mice, we propose that
Chlamydia spp. evolved resistance to IFN--inducible caspase activation primarily to
avoid the lytic destruction of its inclusions. Thus, chlamydial PCDR may have evolved as
a serendipitous by-product of a strategy by Chlamydia spp. to protect the integrity of
its inclusion. Igs4 could be a powerful tool to investigate the role of caspase-mediated
cell-autonomous immune responses and programmed cell death pathways in Chla-
mydia pathogenesis using highly tractable mouse models.
MATERIALS AND METHODS
Chlamydia propagation and cell culture. C. muridarum and C. trachomatis serovar L2 strain 434/Bu
were gifts from Harlan Caldwell, NIH-NIAID, and a C. trachomatis serovar L2 strain 434/Bu rifampin-
resistant (rifr) isolate (C. trachomatis rifr) was described previously (33). Chlamydia spp. were propagated
in McCoy or HeLa cells, and EBs were purified by density gradient centrifugation (73). OE129 and C57epi
cells were gifts from Wilbert Derbigny and Ray Johnson. Dulbecco’s modified Eagle’s medium (HyClone)
supplemented with 10% fetal bovine serum, sodium pyruvate (Atlanta Biologicals), nonessential amino
acids (Gibco), and 5 M HEPES buffer (Sigma) (DMEM) was used for cell culture and was supplemented
with mouse recombinant IFN- (R&D Systems).
Library construction and Igs mutant screen. The C. muridarum mutant library was constructed
using 15 mg/ml EMS, similarly to what we described previously (27, 28). Library isolates were plaque-
cloned and then lysed by bead agitation (74). McCoy cell monolayers in 96-well plates were incubated
in fresh DMEM with or without 20 U IFN- for 24 h, infected with equal inocula of library lysates, and
methanol fixed at 24 hpi. Inclusions were labeled with a murine monoclonal antibody against chlamydial
LPS (EVI-H1), a secondary Alexa488-conjugated antibody (Life Technologies), and imaged using an EVOS
FL auto cell imaging microscope. For inclusion assays, cells were fixed in methanol, and inclusions were
antibody labeled. For progeny assays, cells were harvested by scraping and EBs released by bead
agitation. Dilutions were used to infect McCoy cells, and inclusions were counted at 24 hpi.
Inclusion morphology. McCoy cells were grown on glass coverslips and infected by centrifugation
and rocking. The cells were fixed at 24 hpi, labeled with Evans blue, and then labeled with EVI-HI and
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secondary antibody. Coverslips were mounted in Prolong gold antifade reagent with 4=,6-diamidino-2-
phenylindole (DAPI; Life Technologies) and imaged using a Leica DMI6000B microscope.
IFN- and IFNAR-1 and coinfection rescue experiments. McCoy monolayers were incubated with
10 M anti-mouse IFNAR-1 antibody (clone MAR-5A3), an IgG1 isotype control antibody (BioLegend), or
IFNAR-1 antibody and 250 U/ml IFN- (R&D Systems) for 1 h, infected with C. muridarum or Igs4, and fixed
at 24 hpi. Coinfections of McCoy cells with C. trachomatis rifr and C. muridarum or Igs4 were performed
as described previously (33).
C. muridarum genome sequencing. Purified DNA from EBs was treated with NEBNext double-
stranded DNA (dsDNA) Fragmentase (NEB) to generate dsDNA fragments. The TruSeq Nano DNA sample
preparation kit was used to prepare sequencing libraries as per the manufacturer’s protocols (Illumina,
Inc.). Samples were multiplexed and paired-end 100-bp sequenced on an Illumina HiSeq 2500 platform.
Isolation of Igs4 suppressor mutants and Igs4 recombinants. IFN--treated McCoy cells were
infected with Igs4 and incubated for 24 h with or without IFN-. The cells were harvested, a fifth of each
harvest was used to infect new IFN--treated McCoy monolayers, and the entire process was repeated
six times. Cells in 23 out of 96 experiments were heavily infected by passage six, and suppressor isolates
were plaque-cloned from these experiments. For isolation of Igs4 recombinants, IFN--treated McCoy
cells were coinfected with Igs4 and a temperature-sensitive C. muridarum isolate identified by screening
the mutant library for isolates that grew at 37°C but not 40°C (27). Lysates from the coinfection were
passed twice in IFN--treated McCoy cells incubated at 40°C, and then the surviving isolates were
plaque-cloned.
Irgb6 and Irgb10 localization. McCoy cells in DMEM were treated overnight with IFN- or left
untreated and were infected at a multiplicity of infection (MOI) of 1 by centrifugation. Thirty minutes
postcentrifugation, medium with or without IFN- was added. The cells were washed with phosphate-
buffered saline (PBS) at 22 hpi, fixed with cold methanol, washed with PBS, and then blocked for 30 min
at room temperature in buffer containing 5% goat serum and 5% bovine serum albumin (BSA). Cells were
incubated with EVI-H1, rabbit polyclonal anti-Irgb6 antiserum, or rabbit polyclonal anti-Irgb10 antiserum
and stained with Alexa Fluor-conjugated secondary antibodies (Molecular Probes) and Hoescht (15, 32).
The percentage of targeted inclusions was determined as a function of the number of Irgb6- or
Irgb10-positive inclusions divided by the total number of inclusions.
Evaluation of bacterial burden in MEFs. Wild-type, irgm1/ or irgm3/, and atg5/ MEFs were
cultured in DMEM and treated overnight with IFN- or left untreated. MEFs were infected at an MOI of
1 by centrifugation, and then medium with or without IFN- was added. The cells were lysed in 400 l
H2O at 37°C for 10 min before the addition of 100 l 5 250 mM sucrose–10 mM sodium phosphate–5
mM L-glutamic acid pH 7.2 (1 SPG) at 30 hpi. Relative progeny was determined based on infectivity in
untreated McCoy cells.
shRNAs. MEFs were transduced with The RNAi Consortium (TRC) shRNA vectors. Lentivirus was
prepared in HEK293T cells. Cells were selected for expression for a minimum of 48 h with puromycin
(5 g/ml). Knockdown efficiency of 70% was confirmed for each construct using quantitative (qPCR).
TRC shRNA vectors TRCN0000251780 and TRCN0000251781 were used.
Griess assay and Western blotting of iNOS expression. Nitrite was measured using a commercial
Griess assay kit, according to the manufacturer’s instructions. Cells from Griess assay experiments were
used in Western blotting experiments, and the proteins were labeled with anti-iNOS monoclonal
antibody (MAb) (no. 2982S) or anti-murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) MAb
(no. 2118S), followed by a horseradish peroxidase-conjugated MAb antibody (no. 7074; Cell Signaling),
and visualized using SuperSignal West Pico chemiluminescent substrate (Pierce).
Transmission electron microscopy. Cells were fixed with 2.5% glutaraldehyde and 4% formalde-
hyde in PBS for 1 h and then rinsed 3 with 0.1 M sodium cacodylate buffer. Cells were postfixed in 1%
osmium tetroxide and 1% tannic acid, dehydrated, and embedded in epoxy resin. Sections were stained
with uranyl acetate and lead citrate and imaged using a JEOL JEM 1011 microscope with a Gatan 890 4k
by 4k digital camera.
Apoptosis and necrosis inducer and inhibitor experiments. McCoy monolayers were treated with
various concentrations of Z-VAD(OMe)-fmk (Santa Cruz Biotechnology), 50 M necrostatin-1 (Santa Cruz
Biotechnology), 100 m of Z-DEVD-FMK, Z-IETD-FMK, or Z-LEHD-FMK (R&D Systems, Inc.), or dimethyl
sulfoxide (DMSO) vehicle alone for 2 h prior to infection. Cells were infected at an MOI of 0.1, and IFN-
was added in some cases. For inducer experiments, McCoy cells were infected at an MOI of 0.1 (EVI-H1
staining) or at an MO1 of 1 (acridine orange/ethidium bromide staining). At 20 hpi, 1 M staurosporine
(Santa Cruz Biotechnology), 5 ng/ml TNF- (BioLegend-recombinant mouse) and 10 g/ml CHX, or
5 ng/ml TNF- and 10 M ZVAD(OMe)-fmk was added. Cells were stained with acridine orange and
ethidium bromide at 24 hpi or labeled with EVI-H1 as described above. To assay cell death, 4 l of
100 g/ml acridine orange (Sigma) and ethidium bromide (Sigma) were added to DMEM and incubated
15 min at room temperature (RT) (41). To assay inclusion lysis, cells were fixed with methanol, labeled
with EVI-H1, and imaged as described above.
Mouse genital tract infections. Six 10-week-old female C57BL/6J or B6.129S7-IFN-tm1Ts/J (IFN- /
mice) (Jackson Laboratories, Bar Harbor, ME) were treated with 2.5 mg Depo-Provera at 10 and 3 days
prior to infection. Mice were inoculated with C. muridarum or mutants by placing 5 l of SPG containing
50,000 inclusion-forming units into the vaginal vault. The vaginal vault was swabbed (days 3, 7, 10, and
14 and weekly thereafter), and the infections were monitored by counting inclusions (75).
Analysis of variance (ANOVA) models were used to (i) test whether the time trends between
treatment groups were parallel and, if they were parallel, and (ii) determine whether the groups differ
with respect to magnitude of response. An  level of 0.05 was deemed significant.
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